We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Low Helicobacter pylori eradication rates with 4- and 7-day regimens in an Iranian population.
- Authors
MALEKZADEH, REZA; MERAT, SHAHIN; DERAKHSHAN, MOHAMMAD-HASSAN; SIAVOSHI, FARIDEH; YAZDANBOD, ABBAS; MIKAELI, JAVAD; SOTOUDEMANESH, RASOUL; SOTOUDEH, MASOUD; FARAHVASH, MOHAMMAD-JAFAR; NASSERI-MOGHADDAM, SIAVOSH; POURSHAMS, AKRAM; DOLATSHAHI, SHAHAB; ABEDI, BEHNOOSH; BABAEI, MASOUD; ARSHI, SHAHNAM; MAJIDPOUR, ALI
- Abstract
Abstract Background: In Iran, there is insufficient information on the efficacy of Helicobacter pylori eradication regimens shorter than 10 days. This study aims at assessing the efficacy of 4- and 7-day H. pylori eradication regimens in a high-incidence area of gastric cancer in Iran. Methods: Subjects with an endoscopic diagnosis of gastritis, positive urease test, and a histological diagnosis of chronic gastritis were enrolled. Patients were randomly assigned to one of three groups: AOC7 (1000 mg amoxicillin, 20 mg omeprazole, and 500 mg clarithromycin twice daily for 7 days), FOT4 (200 mg furazolidone, 20 mg omeprazole, and 500 mg tetracycline twice daily for 4 days) and FOT7 (the same treatment as the FOT4 group but for 7 days). Sensitivity to these antibiotics was determined in all isolates recovered from culture. The efficacy of eradication was assessed 8 weeks after the end-of-treatment by the 14 C-urea breath test. Results: One hundred and twenty-eight patients were enrolled in the study. Culture was positive for 84 patients and none of these were resistant to amoxicillin, tetracycline or furazolidone, 1.2% were resistant to clarithromycin and 32.1% to metronidazole. Forty-five, 41 and 42 patients were randomly allocated to the AOC7, FOT4, and FOT7 groups, respectively. The intention-to-treat eradication rates were 35.5, 17.1, and 23.8% for the AOC7, FOT4, and FOT7 groups, respectively. Conclusion: Treatment regimens of 4 or 7 days are unacceptable for H. pylori infection in Iran, even in the presence of a favorable sensitivity profile. © 2003 Blackwell Publishing Asia Pty Ltd.
- Subjects
IRAN; HELICOBACTER pylori; STOMACH cancer; HEALTH promotion
- Publication
Journal of Gastroenterology & Hepatology, 2003, Vol 18, Issue 1, p13
- ISSN
0815-9319
- Publication type
Article
- DOI
10.1046/j.1440-1746.2003.02897.x